Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.44 |
| ▸ | SQLE | Q14534 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532598 | 1.00 | KMT2A (0.48) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL14548055 | 1.00 | KMT2A (0.48) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL15824118 | 0.93 | KMT2A (0.45) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL15824117 | 0.93 | KMT2A (0.45) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL7137718 | 0.91 | KMT2A (0.44) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6254158 | 0.85 | KMT2A (0.45) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6254152 | 0.85 | KMT2A (0.45) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL6254150 | 0.85 | KMT2A (0.45) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL15823756 | 0.84 | KMT2A (0.44) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL15823757 | 0.84 | KMT2A (0.44) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| US-5626852-A | HYDROLYSIS OF ACETAL AND/OR KETAL | THE MENNEN COMPANY (US) | 1997-05-06 | — | — | US | claimed |
| EP-0625905-A4 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE. | MENNEN CO (US) | 1997-02-26 | — | — | EP | claimed |
| EP-0625905-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-11-30 | — | — | EP | claimed |
| WO-1994006441-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-03-31 | — | — | WO | claimed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | OSMO LABS PBC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | disclosed |
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS, PBC | 2025-10-09 | — | — | US | disclosed |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | OSMO LABS, PBC | 2025-07-24 | — | — | US | disclosed |
| EP-0919547-B1 | Preparation of polyenaldehydes | HOFFMANN LA ROCHE (CH) | 2002-06-05 | — | — | EP | disclosed |
| US-6224887-B1 | MIXTURE CONTAINING PENETRATION PROMOTER, WATER INSOLUBLE FILM FORMING POLYMER AND SOLVENT | MACROCHEM CORPORATION | 2001-05-01 | — | — | US | disclosed |
| US-5626852-A | HYDROLYSIS OF ACETAL AND/OR KETAL | THE MENNEN COMPANY (US) | 1997-05-06 | — | — | US | disclosed |
| EP-0625905-A4 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE. | MENNEN CO (US) | 1997-02-26 | — | — | EP | disclosed |
| US-5378468-A | Orthoester which produces a fragrant material by hydrolysis at the ph of the skin when applied; deodorant sticks | THE MENNEN COMPANY (US) | 1995-01-03 | — | — | US | disclosed |
| EP-0625905-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-11-30 | — | — | EP | disclosed |
| WO-1994006441-A1 | COMPOSITION CONTAINING BODY ACTIVATED FRAGRANCE FOR CONTACTING THE SKIN AND METHOD OF USE | THE MENNEN COMPANY (US) | 1994-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250313523-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CYP8B1, CYP1B1, BBOX1 | KMT2A 2702/4885MEN1 1752/4885CYP3A4 296/4885 |
| US-20260028554-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING AROMATIC DERIVATIVES | TAS2R42, TAS2R4, TAS2R41 | KMT2A 733/4885MEN1 2841/4885CYP3A4 216/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | KMT2A 3395/4885MEN1 4840/4885CYP3A4 205/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | KMT2A 3953/4885MEN1 3787/4885CYP3A4 1503/4885 |
| US-20250234910-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING THIENYL ALKANOATE DERIVATIVES | TAS1R3, TAS2R5, TRPA1 | KMT2A 1479/4885MEN1 2909/4885CYP3A4 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.